Technical Analysis for KYMR - Kymera Therapeutics, Inc.

Grade Last Price % Change Price Change
C 39.32 -3.10% -1.26
KYMR closed down 3.1 percent on Monday, March 18, 2024, on 1.43 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Multiple of Ten Bearish Other 0.00%
Oversold Stochastic Weakness 0.00%
Pocket Pivot Bullish Swing Setup -3.10%
Bollinger Band Squeeze Range Contraction -3.10%
Multiple of Ten Bullish Other -3.10%
BB Squeeze Started Range Contraction -3.10%
Fell Below 20 DMA Bearish -0.48%
Multiple of Ten Bearish Other -0.48%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low about 13 hours ago
Possible Inside Day about 15 hours ago
Down 3% about 19 hours ago
Down 2 % about 19 hours ago
Down 1% about 19 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Immunology Solid Tumors Immune System Autoimmune Disease Autoimmunity Rheumatoid Arthritis Hematologic Malignancies Atopic Dermatitis Dermatitis Hidradenitis Suppurativa

Is KYMR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 45.31
52 Week Low 9.6
Average Volume 804,158
200-Day Moving Average 23.87
50-Day Moving Average 35.73
20-Day Moving Average 41.70
10-Day Moving Average 41.58
Average True Range 2.13
RSI (14) 48.98
ADX 39.05
+DI 18.84
-DI 15.88
Chandelier Exit (Long, 3 ATRs) 38.91
Chandelier Exit (Short, 3 ATRs) 42.77
Upper Bollinger Bands 45.01
Lower Bollinger Band 38.38
Percent B (%b) 0.14
BandWidth 15.89
MACD Line 1.38
MACD Signal Line 2.16
MACD Histogram -0.7888
Fundamentals Value
Market Cap 2.33 Billion
Num Shares 59.4 Million
EPS -2.86
Price-to-Earnings (P/E) Ratio -13.75
Price-to-Sales 46.41
Price-to-Book 5.59
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.56
Resistance 3 (R3) 42.84 42.04 42.02
Resistance 2 (R2) 42.04 41.21 41.90 41.84
Resistance 1 (R1) 40.68 40.71 40.28 40.40 41.66
Pivot Point 39.88 39.88 39.68 39.74 39.88
Support 1 (S1) 38.52 39.05 38.12 38.24 36.98
Support 2 (S2) 37.72 38.55 37.58 36.80
Support 3 (S3) 36.36 37.72 36.62
Support 4 (S4) 36.08